A study to assess the effectiveness and safety of Combination of Omega-3 Fatty Acids and Vitamin E versus Combined Oral Contraceptive Pills in Polycystic Ovarian Syndrome
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2024/04/066435
- Lead Sponsor
- Pandit B. D. Sharma UHS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Females of age group (15-45 years).
2.Subjects diagnosed with PCOS according to modified 2018 criteria (Rotterdam criteria): Presence of 2 out of 3 traits.
a.v Presence of Hyperandrogenism (clinical and/or biochemical)
b.v Oligo/Anovulation
c.v PCOM (Polycystic ovarian morphology)- at least one ovary with
i=20 follicles per ovary in either ovary
ii=10 cm3 of ovarian volume
3.Patients willing to give written informed consent/assent.
1.Any history of Neoplastic disease.
2.Endocrinal disorders like Hyperprolactinemia, Hyper/ Hypo Thyroidism and Acromegaly.
3.Functional Hypothalamic amenorrhoea.
4.Already on PCOS treatment or have taken Vitamin supplements in the last 3 months.
5.Females who are either pregnant, willing to become pregnant or lactating.
6.Any Chronic Liver or renal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method